| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.86B | +3.4% |
| Cost of Revenue | $1.16B | +5.0% |
| Gross Profit | $2.71B | +2.8% |
| R&D Expense | $346.8M | +13.6% |
| SG&A Expense | $1.70B | +1.7% |
| Operating Income | $643.3M | +0.1% |
| Pre-tax Income | $641.2M | +7.0% |
| Income Tax | $196.2M | -17.4% |
| Net Income | $445.1M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $937.4M | -0.5% |
| Accounts Receivable | $903.4M | +5.1% |
| Inventory | $296.9M | -12.4% |
| Current Assets | $2.45B | +0.9% |
| Total Assets | $6.08B | +2.3% |
| Current Liabilities | $2.07B | +7.3% |
| Total Liabilities | $2.45B | +4.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $785.8M | +38.2% |
| Capital Expenditures | $177.7M | -39.1% |
| Investing Cash Flow | -$195.9M | +8.1% |
| Financing Cash Flow | -$598.3M | -19.3% |
| Free Cash Flow | $608.1M | +119.6% |
| +23.1% |
| EPS (Basic) | $5.82 | +26.0% |
| EPS (Diluted) | $5.81 | +26.0% |
| Stockholders' Equity |
| $3.63B |
| +0.8% |